CYTK FY 2017 Earnings — Cytokinetics, Incorporated Revenue & Financial Results | Market Cap Arena

CYTKCytokinetics, Incorporated

$8B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$13M-87.4% YoY

Gross Profit

-$77M-575.5% margin

Operating Income

-$113M-848.3% margin

Net Income

-$128M-955.9% margin

EPS (Diluted)

$-2.59

Cash Flow

Operating Cash Flow

-$102M

Free Cash Flow

-$105M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$295M

Total Liabilities

$185M

Stockholders' Equity

$110M

Cash & Equivalents

$125M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$13M	$106M	-87.4%
Gross Profit	-$77M	$42M	-283.1%
Operating Income	-$113M	$19M	-706.8%
Net Income	-$128M	$16M	-876.7%